APA (7th ed.) Citation

Takeda, M. (2020). Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting. Journal of Thoracic Disease, 12(8), 4553-4555. https://doi.org/10.21037/jtd-2020-46

Chicago Style (17th ed.) Citation

Takeda, Masayuki. "Implications of the Success of EGFR-targeted Therapy in Advanced Non–small Cell Lung Cancer for Its Application to the Adjuvant Setting." Journal of Thoracic Disease 12, no. 8 (2020): 4553-4555. https://doi.org/10.21037/jtd-2020-46.

MLA (9th ed.) Citation

Takeda, Masayuki. "Implications of the Success of EGFR-targeted Therapy in Advanced Non–small Cell Lung Cancer for Its Application to the Adjuvant Setting." Journal of Thoracic Disease, vol. 12, no. 8, 2020, pp. 4553-4555, https://doi.org/10.21037/jtd-2020-46.